Graham Capital Management, L.P. Biomarin Pharmaceutical Inc Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 7,329 shares of BMRN stock, worth $490,603. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,329
Previous 21,782
66.35%
Holding current value
$490,603
Previous $1.9 Million
68.3%
% of portfolio
0.02%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
622Shares Held
183MCall Options Held
1.41MPut Options Held
1.31M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.27 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.26 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$933 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$649 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...